MYNERVA AG

The loss of peripheral sensations, affecting diabetic peripheral neuropathy (DPN)(237 M patients), is a severe risk factor for altered gait biomechanics, balance impairment, increased falls risk and chronic pain development.
MYNERVA produced a peerless revolutionary non-invasive device to tackle all these symptoms, Leia: a groundbreaking device that offers a reprieve from the vicious cycle of pain and sensory loss. It is a wearable neurostimulating device able to restore the sense of touch and alleviate pain through pleasant, non-invasive AI-driven electrical stimulation, all within the familiar form factor of a sock.